Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for its ETF Class
-
Iridium to Participate in Investor Conferences
-
Axon reports Q3 2025 revenue of $711 million, up 31% year over year
-
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025
-
Mercury Systems Reports First Quarter Fiscal 2026 Results
-
Perdoceo Education Corporation Reports Third Quarter and Year to Date 2025 Results
-
Advanced Energy Reports Third Quarter 2025 Results
-
ALLEGIANT TRAVEL COMPANY THIRD QUARTER 2025 FINANCIAL RESULTS
-
Triad Business Bank (OTC Pink – “TBBC”), November 4, 2025, Announces Unaudited Third Quarter 2025 Results
-
Inhibrx Announces Participation in Upcoming Scientific Conferences
-
AudioEye Reports Record Third Quarter 2025 Results
-
Premium Income Corporation Announces Monthly Distribution
-
Tempus Reports Third Quarter 2025 Results
-
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
-
Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
-
Gulfport Energy Reports Third Quarter 2025 Financial and Operating Results
-
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
-
Cirrus Logic Reports Record Fiscal Second Quarter Revenue of $561.0 Million
-
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Personalis Reports Third Quarter 2025 Financial Results
-
Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Arcturus Therapeutics to Attend Upcoming Investor Conferences
-
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
-
Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR
-
NetApp Hosts Second Quarter of Fiscal Year 2026 Financial Results Webcast
-
Align Technology to Speak at Upcoming Financial Conferences
-
Schneider National, Inc. announces participation in upcoming conference
-
SLR Investment Corp. Announces Quarter Ended September 30, 2025 Financial Results
-
Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences
-
Supernus Announces Third Quarter 2025 Financial Results
-
Rapid7 Announces Third Quarter 2025 Financial Results
-
NMI Holdings, Inc. Reports Third Quarter 2025 Financial Results
-
Skyworks Reports Q4 and Full Year FY25 Results
-
Grocery Outlet Holding Corp. Announces Third Quarter Fiscal 2025 Financial Results
-
United Fire Group, Inc. reports third quarter 2025 results
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody
-
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
-
Corsair Gaming Reports Third Quarter 2025 Financial Results
-
Youtooz Acquires UK-Based Collectible Brickset Brand Microdesigns, Expanding Into Premium Brickset Display Models
-
National Duals Invitational Championship Match to Air on ESPN2
-
Catalent’s SMARTag® ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego
-
Kratos Reports Third Quarter 2025 Financial Results
-
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
-
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

